You are about to leave the website of Otsuka Novel Products GmbH and view the content of an external website. Otsuka Novel Products GmbH cannot be held responsible for the content of external websites.
Source: World Health Organization. Global Tuberculosis Report 2022. World Health Organization, Geneva, 2022.
Photo credit: Qilai Shen
Source: World Health Organization. Global Tuberculosis Report 2022. World Health Organization, Geneva, 2022.
Photo credit: Sergey Golovach
Source: World Health Organization. Global Tuberculosis Report 2022. World Health Organization, Geneva, 2022.
Photo credit: Riccardo Venturi
Source: World Health Organization. Global Tuberculosis Report 2022. World Health Organization, Geneva, 2022.
Photo credit: Edwin Tuyay
Source: World Health Organization. Global Tuberculosis Report 2022. World Health Organization, Geneva, 2022. World Health Organization. Tuberculosis Factsheet. Published 21 April 2023. Available at: https://www.who.int/news-room/fact-sheets/detail/tuberculosis (Accessed 01 June 2023).
Photo credit: Qilai Shen
Source: World Health Organization. Global Tuberculosis Report 2022. World Health Organization, Geneva, 2022.
Photo credit: Qilai Shen
Access to Medicine Foundation. Antimicrobial Resistance Benchmark 2021. Available at: https://accesstomedicinefoundation.org/medialibrary/resources/61ee760d03810_Antimicrobial%20Resistance%20Benchmark%20report%202021.pdf (accessed 01 June 2023)
Photo credit: Riccardo Venturi
Source: Based on Treatment Action Group, Reports on Tuberculosis Research Funding Trends, issues from 2005-2022 (Accessed 01 June 2023). All reports available at: https://www.treatmentactiongroup.org/resources/tbrd-report/
Photo credit: Qilai Shen
Tuberculosis (TB) is one of the oldest and most persistent epidemics, still affecting people in every country in the world. The World Health Organization estimates that in 2021, 10.6 million people became newly infected with TB, including 1.2 million children.1
TB is spread through air. It most commonly affects the lungs, but can spread to almost any part of the body. About one quarter of the world population is latently infected with Mycobacterium tuberculosis, the bacteria that cause the disease. Those infected have a 5 to 10% lifetime risk of developing active TB. People with weakened immune systems, such as people living with HIV or diabetes, or people who smoke tobacco, have a much higher risk of falling ill with TB.2
The global progress in eliminating TB has been very slow. The TB incidence rate rose by 3.6% between 2020 and 2021, reversing declines of about 2% per year for most of the previous 2 decades.1 TB is still one of the leading causes of death worldwide.2 In 2021 alone an estimated 1.6 million people died from this infectious disease.1
Yet with proper management, TB is curable. However, even treatment of uncomplicated forms of TB requires taking a number of medicines every day for 4 to 6 months.2
The progress in eliminating TB and curing those affected by it has been eroded by the spread of drug-resistant bacteria. To learn more about drug-resistance, click here.
Otsuka has been searching for new tools to fight TB for over 50 years, and has been one of the leading private sector funders of R&D in the world since 2005.3 It is committed to finding innovative solutions to effectively treat drug-resistant forms of TB, as well as to simplify and shorten treatment.
References
1. World Health Organization. Global Tuberculosis Report 2022. World Health Organization, Geneva, 2022.
2. World Health Organization. Tuberculosis Factsheet. Published on 21 April 2023. Available at: https://www.who.int/en/news-room/fact-sheets/detail/tuberculosis (Accessed 01 June 2023).
3. Based on Treatment Action Group, Reports on Tuberculosis Research Funding Trends, issues from 2006 until 2022 (accessed 01 June 2023). All reports available at: https://www.treatmentactiongroup.org/resources/tbrd-report/
Information current as of 16-06-2023
Reference ONP-DEL-2300015
